Neurological Disorders and Treatments
716 ta ish
EFFECTS OF THE DRUG THIOGAMMA® ON THE SYMPTOMS OF PERIPHERAL DIABETIC POLYNEUROPATHY, AS WELL AS EVALUATION OF THE MENTAL STATUS IN PATIENTS WITH DIABETES MELLITUS AND OTHER DISORDERS OF CARBOHYDRATE METABOLISM.
Djuraeva Aziza Shakhzadeyevna, Akhrorov Kamil Ubaydullayevich
MaqolaOchiq kirishNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20220 iqtibosABISCIENTIFIC ANALYSIS OF THE ROLE OF C-REACTIVE PROTEIN AND HYPERGOMOCYSTEINEMIA IN CAUSE OF CHRONIC ISCHEMIC STROKE
Xatamova Sarvinoz Muyitdinovna, Khaydarova Dildora Kadirovna
MaqolaOchiq kirishNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20220 iqtibosABICURRENT OPTIMIZATION OF CLINICAL AND NEUROLOGICAL CHARACTERISTICS OF THE DEVELOPMENT OF CHRONIC CEREBRAL VASCULAR DISEASE AGAINST A BACKGROUND OF ARTERIAL HYPOTENSION
Mavludakhon Mirkhamzaevna Mamurova, Kasimov Arslanbek Atabayevich, Urinova Dilnavoz Kalandar Kizi +1
MaqolaOchiq kirishNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20220 iqtibosABICLINICAL FEATURES AND EFFICACY OF THE USE OF NOOTROPICS IN THE TREATMENT OF ACUTE PERIOD OF CONCENTRAL BRAIN
Norkulov Nazhmiddin Uralovich, Shodiev Amirkul Shodievich, Ravshanov Davron Mavlonovich
MaqolaOchiq kirishNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20220 iqtibosABITRANSCRANIAL MAGNETIC STIMULATION IN PARKINSON'S DISEASE AS A METHOD OF RECOVERY OF MOTOR AND NON-MOTOR DISORDERS
Khaydarov Nodir Kadirovich, Raimova Malika Mukhamedjanovna, Alikhanov Sardorbek Abduvokhobovich
MaqolaOchiq kirishNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20220 iqtibosABIGLOMERULONEFRITLI BOLALARDA RENIN-ANGIOTENZIN-ALDOSTERON TIZM HOLATI VA ARTERIAL BOSIM DARAJASI
Xolboyev Norbek Aliniyozovich, Abdug'aniyev Husniddin Husan o'g'li, O'rozaliyev Sunnat Yusufjon o'g'li +1
MaqolaOchiq kirishNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20220 iqtibosABI